Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:3998
SEHK:3998Luxury

The Bull Case For Bosideng International Holdings (SEHK:3998) Could Change Following Steady EPS And Higher Dividend

Bosideng International Holdings reported half-year results for the period ended September 30, 2025, with sales of CNY 8,927.64 million and net income of CNY 1,189.37 million, and its board recommended an interim dividend of HK$0.063 (approximately CNY 0.057) per share, payable in January 2026. While basic earnings per share were unchanged year on year at CNY 0.1035, the slight improvement in diluted earnings per share highlights incremental profitability gains even after factoring in...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

Is It Time To Reassess AtriCure After Its Recent Share Price Rebound In 2025

Wondering if AtriCure at around $35 is quietly setting up a value opportunity, or if the market already has it priced just right? You are not alone in asking whether now is the moment to pay closer attention. The stock is up 16.2% year to date and 3.8% over the last month, even though it is still slightly down over 1 year and meaningfully lower over 3 and 5 years. This pattern hints at shifting sentiment and fresh expectations. Recent headlines have focused on AtriCure's progress in cardiac...
NZSE:FPH
NZSE:FPHMedical Equipment

Upgraded Earnings Guidance And Dividend Lift Could Be A Game Changer For Fisher & Paykel Healthcare (NZSE:FPH)

Fisher & Paykel Healthcare has already reported half-year 2025 results showing sales of NZ$1,088.5 million and net income of NZ$213.0 million, alongside higher basic earnings per share and an increased interim dividend. The company also raised its full-year revenue and net profit guidance, signaling management confidence that recent operational momentum can continue. Next, we’ll explore how the upgraded full-year earnings guidance may influence Fisher & Paykel Healthcare’s existing...
SHSE:688278
SHSE:688278Biotechs

3 Global Stocks Estimated To Be Undervalued By Up To 49.1%

As global markets navigate a complex landscape marked by dovish Federal Reserve signals and subdued inflation in Europe, investors are keenly observing opportunities that may arise from these shifting dynamics. In this environment, identifying undervalued stocks becomes crucial, as they can offer potential value when market sentiment is dominated by broader economic concerns.
SZSE:000933
SZSE:000933Metals and Mining

Top Global Dividend Stocks To Consider In December 2025

As global markets navigate a landscape of dovish Federal Reserve signals and mixed economic data, investors are keenly observing the potential for interest rate cuts amid evolving inflation dynamics. With U.S. jobless claims at their lowest since April and consumer confidence sliding, dividend stocks offer a compelling opportunity for those seeking stable income in uncertain times. A good dividend stock typically combines a strong track record of consistent payouts with the potential for...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Is MannKind a Hidden Opportunity After Recent Share Price Slide?

If you are wondering whether MannKind at around $5.59 is a hidden opportunity or a value trap, you are not alone, and that is exactly what we are going to unpack. The stock has slipped around 15.3% year to date and 17.8% over the past year, but it is still up 18.9% over 3 years and 98.2% over 5 years, which highlights how sentiment and risk perception have shifted over time. Recent attention on MannKind has centered on its inhaled insulin Afrezza and its expanding footprint in pulmonary...
OTCPK:TCBC
OTCPK:TCBCBanks

TC Bancshares (TCBC) Q3: Rich 92.9x P/E Tests Confidence in Earnings Rebound

TC Bancshares (TCBC) has just posted its Q3 2025 numbers, with revenue at about $4.9 million, basic EPS of $0.08 and quarterly net income of roughly $0.33 million, setting the tone for a cautiously constructive update. The company has seen revenue move from around $4.1 million in Q3 2024 to about $4.9 million in Q3 2025, while basic EPS shifted from roughly $0.06 to $0.08 over the same period, giving investors a clearer read on how recent profitability trends are feeding into the latest...
NasdaqGS:VRSK
NasdaqGS:VRSKProfessional Services

Is Verisk Analytics Now Fairly Priced After Strategic Refocus On Core Insurance Analytics

Wondering if Verisk Analytics is finally trading at a price that makes sense, or if the recent share moves are just noise in a data heavy story? The stock has inched up about 0.4% over the last week and 4.4% in the last month, but that comes after a tough stretch with shares still down 17.8% year to date and 22.4% over the past year, even though the three year and five year returns remain positive at 25.2% and 19.9% respectively. Recently, investors have been digesting updates around...
DB:TNIE
DB:TNIELeisure

European Value Stocks Priced Below Estimated Worth

As European markets experience a positive upturn, with the pan-European STOXX Europe 600 Index closing 2.35% higher and major single-country indexes also on the rise, investors are increasingly turning their attention to value stocks that may be priced below their estimated worth. In such an environment, identifying stocks that are undervalued can offer opportunities for investors seeking to capitalize on potential market inefficiencies and favorable economic conditions.